Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Debt has become a substantial burden for developing countries due to limited access to financing, rising borrowing costs, currency devaluations and sluggish growth. These factors compromise the countries’ ability to react to emergencies, tackle climate change and invest in their people and the fut...ure. The latest report, A World of Debt, discusses the actions needed to unleash the resources needed to build a more prosperous, inclusive, and sustainable world.
more
A variety of international organizations are involved in mobilizing resources from both public and private
sources and using them to extend development assistance to low-and middle-income countries around the world. They provide country-focused financial and technical assistance to developing count...ries, and contribute to the generation of global public goods,
such as disease surveillance, norms and standards,
data and knowledge, and aid coordination
more
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 st...rategy.
more
Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assi...stance for health. This year’s updated estimates show that despite lackluster economic growth and fiscal cutbacks in many developed countries, total assistance remained steady, reaching an all-time high of $31.3 billion in 2013. While annual increases have leveled off since 2010, continued international funding is a sign of the international development community’s enduring support for global health.
The report also shows shifts in sources of financing. As funding from many bilateral donors and development banks has declined, growth in funding from the GAVI Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, non-governmental organizations, and the UK government is counteracting these cuts. Development assistance for different health issues is tracked up to 2011, revealing that the greatest increase in funding was for maternal, newborn, and child health.
more
Der Globale Fonds (GF) ist ein unverzichtbares Finanzierungsinstrument für die effektive Bekämpfung der drei großen Epidemien Aids, Tuberkulose und Malaria. Zu seinen Grundprinzipien gehören die Ausrichtung auf Wirksamkeit der Präventions- und ...Behandlungsprogramme, die Einbindung aller wichtigen zivilgesellschaftlichen Akteure und Communitys, der Fokus auf die Umsetzung menschenrechtsbasierter Ansätze, Country Ownership sowie transparente Entscheidungsprozesse einschließlich der Mittelvergabe. 2019 sagte Deutschland für die 6. Wiederauffüllungskonferenz für den Zeitraum bis 2022 eine Milliarde Euro zu. 2020 kamen Sonderzahlungen in Höhe von 150 Mio € für den vom GF eingerichteten Covid-19-Krisenreaktionsmechanismus (Covid-19 RM) zur Eindämmung der Pandemie hinzu, in 2021 nochmals 140 Mio. €. Der Mehrbedarf zur Bewältigung der Covid-19 Pandemie ist jedoch unabhängig vom Bedarf für die Bekämpfung von Aids, Tuberkulose und Malaria zu betrachten. Dieser Mehrbedarf darf nicht über das Kernbudget für die Programme des Globalen Fonds gedeckt werden.
more
Fifth Edition of the Civil Society Appraisal of the Political and Financial Contributions provided by the German Government in support of the UN Targets on Global Health and HIV Control
How has funding to developing countries for health improvement changed in the wake of the global financial crisis? The question is vital for policy making, planning, and advocacy purposes in donor and recipient countries alike. We measured the total... amount of financial and in-kind assistance that flowed from both public and private channels to improve health in developing countries during the period 1990–2011
more
An unprecedented amount of money is being pledged and used to fund health research and services throughout the
world. Although estimates are diffi cult to obtain, the 2004 estimate for international health funding was about
US$14 billion, and is rapidly increasing, largely because of the emergence... and growth of the Bill & Melinda Gates Foundation (BMGF) and the US Government’s AIDS initiative
more
The World Health Organization (WHO) has developed this report to monitor progress and identify areas for action in the implementation of sodium reduction policies and other measures within Member States and across WHO regions and World Bank income groups. For the first time, a Sodium Country Score f...rom 1 (the lowest level) to 4 (the highest level) is allocated to each Member State based on the level of implementation of sodium reduction policies and other measures. The Sodium Country Score is used to estimate the impact of policy progress on population dietary sodium intake and cardiovascular disease.
more
Past the crucial midpoint to the SDGs, the 2024 SDG3 GAP progress report, ‘Aligning for country impact’, focuses on alignment as the overarching principle linking efforts to deliver greater impact in countries on the health-related SDGs. It contributes to the basis for further discussions among ...the 13 signatory agencies, on how to further improve the alignment and collaboration across multilateral agencies, as will the forthcoming Independent Evaluation findings due in late 2024.
more
The Global Leprosy Strategy 2021–2030 “Towards zero leprosy” was developed through a broad consultative process with all major stakeholders during 2019 and 2020. Valuable inputs were provided by national leprosy programme managers, technical a...gencies, public health and leprosy experts, funding agencies and persons or members of communities directly affected by leprosy.
The Strategy aims to contribute to achieving the Sustainable Development Goals. It is structured along four pillars:
(i) implement integrated, country-owned zero leprosy road maps in all endemic countries;
(ii) scale up leprosy prevention alongside integrated active case detection;
(iii) manage leprosy and its complications and prevent new disability; and
(iv) combat stigma and ensure human rights are respected. Interruption of transmission and elimination of disease are at the core of the Strategy.
more
The Global Strategic Preparedness and Response Plan (SPRP) for mpox, covering the six-month period from September 2024 to February 2025, provides a framework for public health preparedness and response to the mpox emergency. The current draft, subje...ct to Member State input, outlines the urgent actions needed at global, regional, and national levels.
more
The global prevalence, morbidity and mortality related to childhood asthma among children has increased significantly over the last 40 years. Although asthma is recognized as the most common chronic disease in children, issues of underdiagnosis and ...undertreatment persist. There are substantial global variations in the prevalence of asthma symptoms in children, with up to 13-fold differences between countries. The rising number of hospital admissions for asthma may reflect an increase in asthma severity, poor disease management and/or the effect of poverty. The financial burden of asthma is relatively high within developed countries (those for which data is available) spending 1 to 2% of their healthcare budget on this condition. Established in 1989, the Global Initiative for Asthma (GINA) attempts to raise awareness about the increasing prevalence of asthma, improve management and reduce the burden of asthma worldwide. Despite global efforts, GINA has not achieved its goal, even among developed nations. There are multiple barriers to reducing the global burden of asthma, including limited access to care and/or medications, and lack of prioritization as a public healthcare priority. In addition, the diversity of healthcare systems worldwide and large differences in access to care require that asthma management guidelines be tailored to local needs.
more
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
Collaboration between The Lancet and Imperial College London, UK, has resulted in a new Commission, which examines how medical technology should best be used to improve health in low- and middle-income countries. The report concludes that in many cases, medical technology—almost exclusively develo...ped in rich countries—is simply inappropriate for use in poorer nations
more
The Lancet Global Health, Volume 2, Issue 6, Pages e334 - e345, June 2014
doi:10.1016/S2214-109X(14)70213-X